Delaware Chapter of the American College of CardiologyOur purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments. |
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- First Medical Contact in ACS: NCDR and the Latest GuidelinesA recent JACC: Advances Viewpoint examines the challenges associated with implementing revisions to the definition of first medical contact (FMC) introduced in the 2025 ACC/AHA ACS Guideline and its implications for NCDR data collection, specifically for the ACC's Chest Pain – MI Registry.
- SirPAD Redefines Drug-Coated Balloon Therapy in PADPeripheral artery disease (PAD) affects >113 million people worldwide and remains a major cause of limb loss, cardiovascular morbidity, and cardiovascular mortality.
- Twenty-Five Years Later: Remembering Sept. 11Today marks 25 years since Sept. 11, 2001 – a day forever etched into our collective memory. For those of us who lived through that morning, it can seem both a lifetime ago and only yesterday.
- ACC, STS and SCAI Issue Joint Statement on TAVR National Coverage DeterminationThe American College of Cardiology (ACC), Society of Thoracic Surgeons (STS) and Society for Cardiovascular Angiography & Interventions (SCAI) released the following joint statement on the transcatheter aortic valve replacement (TAVR) national coverage determination finalized by the Centers for Medicare and Medicaid Services (CMS).
- Look AHEAD: IL-6, Not hs-CRP, Identifies Risk of HF in Patients With T2D, Overweight/ObesityThe inflammatory biomarker interleukin (IL)-6 identified residual inflammatory risk of incident heart failure (HF) in patients with type 2 diabetes (T2D) and overweight/obesity, particularly among those with no history of cardiovascular disease, according to results of a Look AHEAD ancillary study published Sept. 3 in JACC: Heart Failure.



